FAM120A Couples SREBP-dependent Transcription and Splicing of Lipogenesis Enzymes Downstream of MTORC1
Overview
Authors
Affiliations
The mechanistic target of rapamycin complex 1 (mTORC1) is a master regulator of cell growth that stimulates macromolecule synthesis through transcription, RNA processing, and post-translational modification of metabolic enzymes. However, the mechanisms of how mTORC1 orchestrates multiple steps of gene expression programs remain unclear. Here, we identify family with sequence similarity 120A (FAM120A) as a transcription co-activator that couples transcription and splicing of de novo lipid synthesis enzymes downstream of mTORC1-serine/arginine-rich protein kinase 2 (SRPK2) signaling. The mTORC1-activated SRPK2 phosphorylates splicing factor serine/arginine-rich splicing factor 1 (SRSF1), enhancing its binding to FAM120A. FAM120A directly interacts with a lipogenic transcription factor SREBP1 at active promoters, thereby bridging the newly transcribed lipogenic genes from RNA polymerase II to the SRSF1 and U1-70K-containing RNA-splicing machinery. This mTORC1-regulated, multi-protein complex promotes efficient splicing and stability of lipogenic transcripts, resulting in fatty acid synthesis and cancer cell proliferation. These results elucidate FAM120A as a critical transcription co-factor that connects mTORC1-dependent gene regulation programs for anabolic cell growth.
Jefcoate C, Larsen M, Song Y, Maguire M, Sheibani N Int J Mol Sci. 2025; 26(5).
PMID: 40076634 PMC: 11901102. DOI: 10.3390/ijms26052011.
The splicing factor SRRM2 modulates two S6K kinases to promote colorectal cancer growth.
Yan Z, He L, Yuan J, Niu Y, Shuai S, Luo S Oncogene. 2025; .
PMID: 39956864 DOI: 10.1038/s41388-025-03307-1.
mTORC1, the maestro of cell metabolism and growth.
He L, Cho S, Blenis J Genes Dev. 2024; 39(1-2):109-131.
PMID: 39572234 PMC: 11789495. DOI: 10.1101/gad.352084.124.
FAM120A deficiency improves resistance to cisplatin in gastric cancer by promoting ferroptosis.
Niu L, Li Y, Huang G, Huang W, Fu J, Feng L Commun Biol. 2024; 7(1):399.
PMID: 38565940 PMC: 10987584. DOI: 10.1038/s42003-024-06097-6.
Rashidpour A, Wu Y, Almajano M, Fabregas A, Meton I Mar Drugs. 2023; 21(11).
PMID: 37999386 PMC: 10672111. DOI: 10.3390/md21110562.